Instil Bio Inc expected to post a loss of 44 cents a share - Earnings Preview

Instil Bio

11/11/2022 13:16

* Instil Bio Inc  TIL.OQ   TIL.O  is expected to show no
change in
quarterly revenue when it reports  results on November 14
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Instil Bio Inc is
for a
loss of 44 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Instil Bio
Inc is
$14​, above​ its last closing price of $2.42. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.38       -0.41      -0.46     Missed  -11.7
 Mar. 31 2022  -0.38       -0.38      -0.42     Missed  -9.6
 Dec. 31 2021  -0.36       -0.36      -0.43     Missed  -18.6​
 Sep. 30 2021  -0.32       -0.32      -0.33     Missed  -1.9
 ​​Jun.        -0.21       -0.20      -0.27     Missed  -31.7
 30 2021                                                
 Mar. 31 2021  -0.52       -0.52      -0.66     Missed  -27.5​
 This summary was machine generated November 11 at 13:16 GMT. 
All figures in US dollars  unless otherwise stated